Human skin replacement - Clinical Cell CultureAlternative Names: CellSpray; CellSpray XP
Latest Information Update: 04 May 2005
At a glance
- Originator Clinical Cell Culture
- Class Cell therapies
- Mechanism of Action Tissue replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Burns
Most Recent Events
- 09 Sep 2003 Preregistration for Burns in Belgium (Topical)
- 09 Sep 2003 Clinical Cell Culture has filed a marketing approval application with the Belgium Ministry of Health for Burns